These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9207783)

  • 1. The extent of genetic variation in the CCR5 gene.
    Ansari-Lari MA; Liu XM; Metzker ML; Rut AR; Gibbs RA
    Nat Genet; 1997 Jul; 16(3):221-2. PubMed ID: 9207783
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural resistance to HIV?
    Hill CM; Littman DR
    Nature; 1996 Aug; 382(6593):668-9. PubMed ID: 8751431
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group.
    Theodorou I; Meyer L; Magierowska M; Katlama C; Rouzioux C
    Lancet; 1997 Apr; 349(9060):1219-20. PubMed ID: 9130946
    [No Abstract]   [Full Text] [Related]  

  • 4. [Genetic polymorphism of human immunodeficiency virus coreceptor CCR5Delta32 and CCR2-64I alleles in Chinese Yi Ethnic group in Sichuan].
    Deng XL; Hong KX; Chen JP; Ruan YH; Xu MY; Qin GM; Li K; Xing H; Shao YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1050-3. PubMed ID: 15769362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 infection in an individual homozygous for the CCR5 deletion allele.
    Biti R; Ffrench R; Young J; Bennetts B; Stewart G; Liang T
    Nat Med; 1997 Mar; 3(3):252-3. PubMed ID: 9055842
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-1 infection in a man homozygous for CCR5 delta 32.
    O'Brien TR; Winkler C; Dean M; Nelson JA; Carrington M; Michael NL; White GC
    Lancet; 1997 Apr; 349(9060):1219. PubMed ID: 9130945
    [No Abstract]   [Full Text] [Related]  

  • 7. Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group.
    Garred P; Eugen-Olsen J; Iversen AK; Benfield TL; Svejgaard A; Hofmann B
    Lancet; 1997 Jun; 349(9069):1884. PubMed ID: 9217763
    [No Abstract]   [Full Text] [Related]  

  • 8. In search of AIDS-resistance genes.
    O'Brien SJ; Dean M
    Sci Am; 1997 Sep; 277(3):44-51. PubMed ID: 9274039
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethics of AIDS study.
    Gomperts ED; Donfield SM
    Science; 1996 Dec; 274(5293):1596. PubMed ID: 8984621
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV CCR5 resistance incomplete.
    Smith O
    Nat Med; 1997 Apr; 3(4):372-3. PubMed ID: 9095162
    [No Abstract]   [Full Text] [Related]  

  • 11. [Polymorphism of human alleles associated with genetic resistance against HIV-1 infection and its implications].
    Wang F; Liu D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):285-7. PubMed ID: 10932017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression.
    Tang J; Rivers C; Karita E; Costello C; Allen S; Fultz PN; Schoenbaum EE; Kaslow RA
    Genes Immun; 1999 Sep; 1(1):20-7. PubMed ID: 11197301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia.
    Kamkamidze G; Capoulade-Metay C; Butsashvili M; Dudoit Y; Chubinishvili O; Debre P; Theodorou L
    Georgian Med News; 2005 Jan; (118):74-9. PubMed ID: 15821335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS research. Receptor mutations help slow disease progression.
    Cohen J
    Science; 1996 Sep; 273(5283):1797-8. PubMed ID: 8815542
    [No Abstract]   [Full Text] [Related]  

  • 15. 32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes.
    Rappaport J; Cho YY; Hendel H; Schwartz EJ; Schachter F; Zagury JF
    Lancet; 1997 Mar; 349(9056):922-3. PubMed ID: 9093257
    [No Abstract]   [Full Text] [Related]  

  • 16. [Frequency of the mutated allele of CCR-5 receptor in HIV-1 positive and negative individuals in the Province of Chaco].
    Motta P; Cibulsky L; Iliovich E; Habegger de Sorrentino A
    Medicina (B Aires); 2000; 60(4):431-4. PubMed ID: 11188946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR5-delta 32 gene deletion in HIV-1 infected patients.
    Michael NL; Louie LG; Sheppard HW
    Lancet; 1997 Sep; 350(9079):741-2. PubMed ID: 9291931
    [No Abstract]   [Full Text] [Related]  

  • 18. CCR5-delta 32 gene deletion in HIV-1 infected patients.
    Smith MW; Dean M; Carrington M; Huttley GA; O'Brien SJ
    Lancet; 1997 Sep; 350(9079):741; author reply 742. PubMed ID: 9291930
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic variation observed at three tetrameric short tandem repeat loci HumTHO1, TPOX, and CSF1PO--in five ethnic population groups of northeastern India.
    Ranjan D; Kashyap VK
    Am J Hum Biol; 2001; 13(1):23-9. PubMed ID: 11466963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant gene blocks HIV's entry into cells.
    NIAID AIDS Agenda; 1996 Sep; ():6. PubMed ID: 11363925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.